The gene expression profile of cumulus cells reveals altered pathways in patients with endometriosis by Allegra, A. et al.
REPRODUCTIVE PHYSIOLOGYAND DISEASE
The gene expression profile of cumulus cells reveals altered
pathways in patients with endometriosis
Adolfo Allegra & Stefania Raimondo & Aldo Volpes & Daniele Fanale & Angelo Marino &
Giuseppe Cicero & Giacomo De Leo & Francesca Sammartano & Giulia Allegra &
Riccardo Alessandro
Received: 12 February 2014 /Accepted: 21 July 2014
# Springer Science+Business Media New York 2014
Abstract
Purpose The objective of this experimental study was to
compare the global gene expression profile of CC of mature
oocytes in 18 patients with severe endometriosis and CC in 18
control patients affected by a severe male factor.
Methods For each group, the CC were pooled, RNA was
extracted and a microarray performed. For validating the
microarray, a quantitative real-time PCR was performed in
the CC of an independent set of patients with endometriosis
(n=5) and controls (n=7).
Results 595 differentially expressed genes (320 down-regu-
lated, 275 up-regulated, p<0.05, fold change ≥1.5) were iden-
tified. The most significant changes were observed in genes
involved in the chemokine signaling and cell-cell or cell-
extracellular matrix adhesion pathways. Several genes of the-
se pathways were down-regulated in endometriosis.
Individual RT-PCR assays confirmed the microarray for ten
genes.
Conclusions Several genes involved in the chemokine
mediated-signaling pathway and in the functional cross-talk
between CC and the oocyte are down-regulated in endometri-
osis CC. The impairment of these processes could explain the
reduction of oocyte competence in endometriosis. This pre-
liminary knowledge could be the starting point for a more
detailed elucidation of the relationship between endometriosis
and oocyte competence.
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Introduction
The effect of endometriosis on assisted reproductive
treatments is controversial. A milestone meta-analysis
of observational studies has demonstrated that patients
with endometriosis-associated infertility have shown a
decrease in the number of retrieved oocytes, in fertili-
zation, implantation, and pregnancy rates, in comparison
with patients affected by tubal factor infertility [1].
Furthermore, pregnancy rates in patients with severe
endometriosis were significantly lower than those of
patients with mild disease [1]. Based on the results of
this meta-analysis, in 2005 ESHRE guidelines for the
diagnosis and treatment of endometriosis [2] have indi-
cated a high level of evidence with grade A strength for
the reduction of pregnancy rates in patients with endo-
metriosis, compared to those with tubal infertility. In
2012, the Practice Committee of the American Society
for Reproductive Medicine [3] concurred with this
conclusion.
Capsule Several genes involved in the chemokine mediated-signaling
pathway and in the cross-talk between cumulus cells and the oocyte are
down-regulated in the cumulus cells of patients with endometriosis.
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In a large database-cohort study, decreasing fertilization
and pregnancy rates were observed in patients with endome-
triosis, compared to patients with other causes of infertility [4].
Nevertheless, the findings of these studies contrast with data
coming from the registry of the Society for Assisted
Reproductive Technology (SART). Here, patients with endo-
metriosis shared similar implantation, pregnancy and delivery
rates, compared with those patients affected by other causes of
infertility [5]. The discrepancy between the first two studies
[1, 4] and the last [5] may be due to the fact that data from
national registries are not adjusted for confounding variables.
Taking into account these last data, the new ESHRE guide-
lines [6] did not indicate the same level of evidence as the
previous guidelines [2] for the reduction of pregnancy rates in
patients with endometriosis. Furthermore, other clinical stud-
ies have demonstrated a major impairment in oocyte quality in
patients with endometriosis. A study carried out on oocyte
donors revealed that recipients with endometriosis did not
show a reduced pregnancy rate. On the contrary, the oocytes
retrieved by donors with endometriosis led to a statistically
significant decrease in pregnancy rates in recipients, thereby
demonstrating a direct effect of endometriosis on oocyte and
embryo quality rather than on endometrial receptivity [7]. The
results of this study have been confirmed by other observa-
tions, suggesting that an altered follicular microenvironment
in patients with endometriosis could be responsible for a
defective oogenesis and subsequently low fertilization rates
or poor quality embryos with a reduced ability to implant [8].
In order to evaluate oocyte competence, a non-invasive
method has been proposed, involving the gene expression
analysis of cumulus cells (CC). These cells surround the oocyte
and establish a functional bidirectional cross-talk with the oo-
cyte through gap junctions and paracrine factors. Several stud-
ies have been published, demonstrating that the gene expression
of CCmay differ in relation to the potential development of the
embryo [9–15]. Furthermore, a relationship between the kind of
stimulation during an IVF cycle and differences in the gene
expression profile of CC has been demonstrated [9, 15–17].
As far as is known, no genome-wide expression study on
CC of mature oocytes in patients affected by severe endome-
triosis has been published. The available evidence supports
the thesis that modifications in granulosa cells may impair
follicular growth and oocyte quality in patients with endome-
triosis [18]. Increased apoptotic activity, related to the severity
of the disease, has been described in the granulosa cells of
endometriosis patients, resulting in poor oocyte quality and a
reduction in fertilization and pregnancy rates [19].
Commencing with these initial observations, the objective
of this study was a comparison of the global gene expres-
sion profile of CC, associated with mature oocytes isolated
from patients affected by severe endometriosis, and from
control patients referred for in vitro fertilization for a
severe male factor.
Material and methods
Patient population and ovarian stimulation
In this experimental study, CC obtained from 18 patients
attending an intracytoplasmic sperm injection (ICSI) cycle
for severe endometriosis (Group A) were compared to control
CC obtained from 18 patients attending an ICSI cycle for
severe male factor (Group B) at the ANDROS Day Surgery
Clinic Reproductive Medicine Unit in Palermo, Italy. The
patients with endometriosis underwent ICSI in order to have
two groups treated in the same way, avoiding any bias. The
diagnosis of severe endometriosis (stage III-IVof the ASRM
revised classification) [20] was performed by laparoscopy or
laparotomy and histologically confirmed. No patient had an
ovarian endometrioma at the moment of enrollment to the
study.
Severe male factor infertility was defined as a sperm count
≤5.000.000/ml or azoospermia. The inclusion criteria were as
follows:
& the patients were at least 18 years of age but not >38 years
& they had a BMI of between 18 and 30 kg/m2 and
& normal regular menstrual cycles, ranging from 24 to
35 days in length, basal serum FSH ≤12 mIU/mL, basal
AMH level between 0.6 and 6 ng/ml, normal thyroid-
stimulating hormone (TSH) and prolactin levels, and nor-
mal uterine cavity as assessed by hysteroscopy.
Those patients affected by polycystic ovary syndrome or
other anovulatory causes of infertility were excluded.
Controlled ovarian hyperstimulation was performed after pi-
tuitary down-regulation with a gonadotrophin-releasing
hormone agonist (GnRH-a, leuprolide acetate; 3.75 IM)
(Enantone; Takeda Chemical Industries, Osaka, Japan),
administered on day 21 of the previous cycle.
Multifollicular development was achieved by daily in-
jections of recombinant FSH (Gonal F; Serono, Rome,
Italy), commencing after at least 12 days of pituitary
down-regulation.
Treatment with a fixed dose of recombinant FSH was
initiated for five days and then adjusted, according to the
response of the ovaries to stimulation. Oocyte maturation
was triggered with an injection of 10,000 IU of human chori-
onic gonadotropin (hCG, Gonasi HP; IBSA, Switzerland)
after at least 10 days of FSH therapy and when three follicles
reached 16 mm. The oocyte pick-ups were carried out 36 h
after the triggering of oocyte maturation. ICSI and embryo
transfer procedures were performed according to the protocols
described in Volpes et al., 2004 [21]. The study was approved
by the local Ethical Committee (the Ethical Committee of the
ANDROS Day Surgery Clinic, Palermo, approval date 22/01/
2010, Cod. 01/MR/10).
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Isolation and collection of cumulus cells
After oocyte pick up, every oocyte surrounded by its own CC
was cultured individually in 30 μl microdrops of culture media
(ISM1, Origio) undermineral oil (Liquid Paraffin, Origio) for at
least two hours [22]. Decoronization was carried out by placing
each cumulus oocyte complex (COC) in separated drops of
recombinant human hyaluronidase (ICSI cumulase, Origio)
under oil. Sterile plastic strippers were used (Stripper Tips,
Origio) to separate the oocyte from the cumulus cells.
The oocyte was then washed in 30 μl microdrops of a
HEPES buffered medium (Flushing Medium, Origio) under
oil, and nuclear maturation was evaluated by using an inverted
microscope at 400 magnification. The collected oocytes were
classified as follows: mature oocytes (MII), immature oocytes
(MI and germinal vesicles GV). Drops containing CC from
immature oocytes were discarded.
All the cumulus cells associated with mature oocytes were
aspirated from drops of recombinant human hyaluronidase for
each patient, pooled and placed into a conical plastic tube
containing 10 ml of sterile saline solution. The tube was
centrifuged, the supernatant was discarded and the pellet
was re-suspended in 1 ml of fresh sterile saline solution. A
second centrifugation was performed by using a 1 ml conical
Eppendorf tube. The supernatant was discarded, the pellet was
re-suspended in 0.5 ml of RNAlater solution (Ambion, TX,
USA) and the Eppendorf tube was cryo-preserved at −80 °C.
RNA isolation and microarray analysis
Prior to RNA extraction, oophorus cumuli from 18 endome-
triosis patients and from 18 control patients were pooled. A
pooled sample containing 77 oophorus cumuli was obtained
for the endometriosis group (group A), and 110 oophorus
cumuli were collected from the control group (group B).
Total RNA was extracted from CC, according to the manu-
facturer’s protocol (Affymetrix, Santa Clara, CA). Quantity
and purity were determined for all RNA samples using a
Nanodrop ND-1000 spectrophotometer (Nanodrop
Technologies Celbio, Italy) and RNA integrity was assessed
using a Bioanalyzer 2100 (Agilent Technologies, Santa Clara,
CA, USA). A microarray analysis was performed, according
to the manufacturer’s instructions (Affymetrix, Santa Clara,
CA) by using the Two-Cycle Target Labeling and Control
Reagents kit (Affymetrix, Santa Clara, USA). The two-cycle
labeling protocol consisted of two successive rounds of T7-
based in vitro transcription, incorporating biotin rNTPs in the
second round reaction. Fifty nanograms of total RNA were
amplified using the two-cycle cDNA synthesis kit (Affymetrix,
Santa Clara, USA), in combination with the MEGA script T7
in vitro transcription system (Ambion, TX, USA). Two bio-
logical replicates were performed for each experimental con-
dition. AffymetrixGeneChip Operating Software (Affymetrix
GCOS v1.4) was used to analyze the image data. The quality
control of the arrays was performed using AffyQCReport
software [23] and comparable quality between probe arrays
was demanded for all arrays in each experiment.
Heat Map analyses (HCA) were performed using the
MultiExperiment Viewer (MeV v4.8) program from the
TM4 Microarray Software Suite. An Agene Set Analysis
Toolkit was used to investigate the biological significance of
a set of genes, involved in chemokine signaling pathway, cell-
cell and cell-extracellular matrix (ECM) adhesion mecha-
nisms. Differentially expressed genes were analyzed, accord-
ing to predefined pathways and annotated by KEGG (the
Kyoto Encyclopedia of Genes and Genomes) [24] and
BioCarta (BioCarta Pathways [http://www.biocarta.com/
genes/index.asp]) bio-information resources, using the Gene
Set Analysis Toolkit. A hypergeometric test was applied in
order to determine whether the proportion of the genes falling
into each category (down- and up-regulated) was statistically
significant. For an over-represented KEGG or Biocarta path-
way, a cut-off P value of 0.01was selected. All displayed
values were expressed on a logarithm scale, and it should be
noted that generally one gene can participate in more than one
KEGG or BioCarta pathway.
An analysis of Gene Ontology (GO) was performed on
selected genes. The degree of enrichment or depletion of the
GO category for each group of genes was calculated, as
represented by the specific expression pattern, comparing
the enrichment/depletion with that which could have been
expected by chance alone, using the two-sided Fisher’s exact
test.
RNA isolation and quantitative real-time polymerase chain
reaction (RT-PCR)
A quantitative RT-PCR analysis was performed individually
on an independent set of new patients in order to validate the
microarray-derived results. RNAwas extracted from 5 differ-
ent samples of oophorus cumuli, which had been isolated
from patients with endometriosis, and from 7 samples of
oophorus cumuli, which had been isolated from control pa-
tients; both extractions deployed the commercially available
RNAqueous micro kit (Ambion, TX, USA), as described
previously. Total RNA was reverse transcribed to cDNA,
using a High Capacity cDNA Reverse Transcription Kit
(Applied Biosystems, Foster City, CA, USA). Samples were
stored at −20 °C until use. Regarding quantitative TaqMan
RT-PCR, master mix and TaqMan gene expression assays for
GAPDH (glyceraldehyde 3-phosphate dehydrogenase,
Hs99999905_m1) control, TNFAIP6 (Hs01113602_m1),
CD44 (Hs01075861_m1), TENASCIN C (Hs01115665_m1),
INTEGRIN β2 (Hs00164957_m1), IL-8 (Hs00174103 m1),
CXCL2 (Hs00601975_m1), CYP11A1 (Hs00167984_m1),
RUNX1 (Hs00231079_m1), NLRP2 (Hs01546932_m1) and
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ARHGAP10 (Hs00226305_m1) were obtained from Applied
Biosystems. Samples were run in duplicate using the Step-
One RT-PCR system (Applied Biosystems, Foster City, CA,
USA). Relative changes in gene expression between patients
with endometriosis and controls were determined using the
ΔΔCt method. Levels of the target transcript were normalized
to a GAPDH endogenous control, constantly expressed in
both groups (ΔCt). Additional subtractions were performed
for ΔΔCt values between untreated and treated samples
ΔCtvalues. Final values were expressed as a fold of induction
(FOI).
Statistical analysis
The background subtraction and normalization of probe set
intensities was performed for the statistical analysis using the
Robust Multiarray Analysis (RMA) method, as described by
Irizarry et al. [25]. Gene expression intensity was compared in
order to identify differentially expressed genes, using a moder-
ated t test and a Bayes smoothing approach, which had been
developed for a low number of replicates [26]. To compensate
for the effect of multiple testing, the false discovery rate was
estimated from p values, as derived from moderated t test
statistics [27]. The analysis was performed using the
affylmGUI Graphical User Interface for the limma microarray
package (Bioconductor Software) [28]. A comparison between
patient and cycle characteristics was performed by deploying
the adequate non parametric test (Mann–Whitney U-test).
Results
Gene expression profiling in CC of patients with severe
endometriosis
A microarray analysis was performed in order to characterize
the differential gene expression profiles in CC of patients with
severe endometriosis, using an Affymetrix platform on pooled
RNA samples from patients with endometriosis and control
patients. This analysis permitted us to obtain a list of differ-
entially expressed genes (DEGs) in the CC of women with
severe endometriosis, as compared to healthy women.
Specifically, this list was screened by considering genes with
p<0.05 as only significant and fold change ≥1.5 (linear scale).
Thus, a list of 595 DEGs between the two analysed groups
(320 down-regulated and 275 up-regulated) (Table S1) was
obtained. The 595 DEGs were further analyzed by means of
the Gene Set Analysis Toolkit software and distributed among
the three different GO categories (biological process, molec-
ular function and cell component), making use of pie charts
(Fig. 1). A GO analysis indicated that most DEGs fell into the
following main sub-categories: the biological process
category, biological regulation, metabolic process, response
to stimulus and cell communication; the molecular function
category: protein, ion, nucleic acid and nucleotide binding;
and the cell component category membrane: nucleus,
membrane-enclosed lumen and macromolecular complex.
Furthermore, it was observed that a high percentage of these
genes was shared by the following sub-categories: membrane,
extracellular space, extracellular matrix, cell projection and
cell communication.
The integrated analysis resulting from different databases
(especially, KEGG and the Biocarta bio-information re-
sources) enabled us to identify the main molecular pathways
which had been altered in CC in patients with severe endo-
metriosis. This analysis indicated that the majority of genes
showing a deregulation in expression levels was included in
the following main pathways: cell-cell and cell-ECM interac-
tion (19 genes), chemokine signalling (17 genes), lipid and
lipoprotein metabolism (15genes), cytokine-cytokine receptor
interaction (14 genes), myometrial relaxation and contraction
(12 genes), TNF-alpha/NF-kB signalling (11 genes), NOD-
like receptor signalling (9 genes), apoptosis (7 genes), Toll-
like receptor signalling (7 genes) and cumulus-oocyte com-
plex formation and maturation (6 genes). However, our atten-
tion was focused mainly on the genes involved in cross-talk
between oocyte and CC, and the inflammatory response.
These two pathways were grouped into two distinct heat
maps, using the MultiExperiment Viewer program (MeV
v4.8) (Fig. 2). Indeed, the most significant changes in expres-
sion levels were observed in key genes involved in the che-
mokine signalling pathway (Fig. 2a), and cell-cell and cell-
ECM adhesion mechanisms (Fig. 2b).
Of interest, almost all genes involved in the chemokine
signalling pathway (Fig. 2a), and cell-cell and cell-ECM ad-
hesion mechanisms (Fig. 2b) pathways (except KRAS and
SHC4,and CLDN11 and VCAM1 respectively) underwent a
negative regulation of the expression in the CC of patients
with severe endometriosis. Specifically, the most down-
regulated genes belonged to the chemokine group, including
CXCL2, which demonstrated the highest value for fold change
(−10.3), CCL20 (−8.93), CXCL3 (−6.62) and IL8 (−5.08). Of
the DEGs involved in cell-cell and the cell-ECM interaction
pathway, significant decreases in expression levels were ob-
served in SPP1 (−3.86), MXRA5 (−3.41), TENASCINC
(−3.22), CD44 (−3.01). Finally, the microarray analysis re-
vealed a reduction in the expression levels of genes regulating
COC formation and maturation, such as TNFAIP6, INHBA,
PTGER4, PTGER2, FSTL3 and EREG.
Real time analysis
It was decided to analyse the expression levels of mRNA in
individual endometriosis samples as compared with controls
through single RT-PCR in order to confirm the microarray
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analysis on pooled cumuli. The expression of the seven down-
regulated selected genes (CYP11A1, TNFAIP6, CXCL2,
CD44, TENASCINC, IL8 and INTEGRIN Β2) was investigat-
ed because they belong to two important biological classes
involved in oophorus cumulus and oocyte crosstalk, such as
cell-cell and cell-matrix adhesion and the chemokine path-
ways. Three up-regulated genes (RUNX1, ARHGAP10 and
NLRP2) were selected because they participate in the regula-
tory mechanisms of important physiological processes. The
data confirmed the decreased expression of CYP11A1,
TNFAIP6, CXCL2, CD44, TENASCINC, IL8 and INTEGRIN
Β2 genes in oophorus cumulus cells, which had been collected
from endometriosis patients as compared to those collected
from controls, and a higher expression of RUNX1, ARHG
AP10 and NLRP2 in the same samples (Fig. 3).
Discussion
The mechanisms of endometriosis-associated infertility have
been debated for many years and they are still held to be
unclear. Excluding altered pelvic anatomy, these mechanisms
include: abnormal folliculogenesis, elevated oxidative
stress, altered immune function and reduced endometrial
receptivity. In IVF cycles, these factors lead to poor
oocyte quality, impaired fertilization and implantation
[18]. There is clinical evidence that oocyte competence
is the key mechanism impaired in endometriosis-related
infertility [7, 29, 30].
The pre-ovulatory oocyte is surrounded by several layers of
CC, tightly connected to each other and the oocyte via gap
junctions and intercellular membrane processes, thereby es-
tablishing bi-directional crosstalk. This interaction is crucial
for the functioning of both of the cytotypes, conferring the
competence required for fertilization and embryogenesis on
the oocyte, through the exchange of nutrients, growth factors,
paracrine signals, secondary messengers and other regulatory
molecules [31–34]. For these reasons, the analysis of the gene
expression profile of CC could provide information regarding
oocyte competence. Various microarray-based studies into CC
in humans and other mammals have been performed in recent
years [9–17, 35, 36].
Fig. 1 Pie charts of GO categories. The diagrams summarize the expres-
sion profile microarray data of 595 DEGs, distributed amongst the three
different Gene Ontology (GO) categories: (a) Biological Process, (b)
Molecular Function and (c) Cell Component. Each category is divided
into several sub-categories
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A transcriptomic analysis of CC derived from endometri-
osis patients is still lacking. The aim of this study was to
compare the transcript profiles of CC isolated from patients
with severe endometriosis and controls by means of a wide-
genome expression analysis. A further objective of this anal-
ysis was to identify any pathway potentially responsible for
the low fertilization and implantation rates observed in endo-
metriosis patients. In both groups, the CC associated with
mature oocytes of all patients were pooled together. This
procedure was mandatory due to the very low quantity of
obtained RNA and it has been used by several authors [9,
12, 14, 35, 37–39]. However, the results obtained through
conducting microarrays have been validated by using RT-
PCR on an individual set of patients. Performing the micro-
array analysis, 595 genes (320 down-regulated and 275 up-
regulated) were identified as having been differentially
expressed between those patients suffering from endometri-
osis and the control patients. The genes chosen for the RT-
PCR validation (TNFAIP6, CD44, TENASCIN C, INTEGRIN
Β2, IL8, CXCL2,CYP11A1, RUNX1, NLRP2, ARGHAP10)
were selected according to their biological relevance in the
oocyte maturation process and taking into account the differ-
ences in folds of expression. The RT-PCR results confirmed
the microarray results for all the analysed genes.
Several functional pathways were identified when the ap-
proach outlined in this Paper was adopted. These pathways
share many genes, thereby implying that a single pathway
cannot be considered as a separate and individualized process.
Numerous pathways belong to the field of immunity (Toll-like
receptor signalling, NOD-like receptor signalling, chemokine
signalling, cytokine-cytokine receptor interaction, TNF-alpha/
NF-kB signalling) and cell-cell and cell-ECM adhesion
Fig. 2 Heat maps of DEGs involved in main pathways, deregulated in
the CC of patients with endometriosis. The clustering of DEGs involved
in (a) chemokine signaling pathway and (b) cell-cell and cell-ECM
adhesion mechanisms, identified by integrated analyses using KEGG
and BioCarta databases. For an over-represented KEGG or BioCarta
pathway, a cut-off p value of 0.01 was selected. The heat maps were
generated from microarray data, reflecting gene expression values
(p<0.05 and fold change ≥1.5) in the cumulus oophorus cells of patients
with severe endometriosis (Group a) in comparison to control cells
(Group b). Each row represents the expression levels for a single gene
tested for the two experimental conditions. Each column shows the
expression levels for the genes, which were tested for each group of
individuals. The absolute expression value (log scale) of each gene has
been derived from the mean of two replicates. The color scale bar on the
top represents signal intensity variations, ranging from green (poorly
expressed genes) to red (highly expressed genes). The black boxes
indicate intermediate expression values.
Fig. 3 An RT-PCR analysis of
expression levels of selected
differentially expressed genes in
oophorus cumulus cells from
endometriosis patients vs control.
It is shown the relative expression
of the mRNA of differentially
expressed genes in oophorus
cumulus cells from endometriosis
patients (n=5), normalized for
GAPDH and plotted as a fold of
increase over cumulus cells of
control patients (n=7). Results
represent the mean ± SD
(*P<0.001; **P<0.05)
J Assist Reprod Genet
mechanisms, and the vast majority of the genes involved in
these pathways are down-regulated in endometriosis CC.
Toll-like and NOD-like receptors are known as Pattern
Recognition Receptors (PRR) and are implicated in innate
immunity [40]. These receptors recognize pathogen-
associated molecular patterns (PAMP), produced by patho-
gens, and damage-associated molecular patterns (DAMP),
which are released by the damaged cells of the human organ-
ism. After contact with these molecules, Toll-like and NOD-
like receptors activate NFKB, a transcription factor, which
induces the production of chemokines and inflammatory cy-
tokines, such as: Tnf alpha, IL1, IL6, IL8, IL12 and IL18.
Differing evidence supports the role of inflammation and
the immune response in granulosa and cumulus cells during
the ovulation process [41, 42]. Follicular rupture and ovula-
tion are characterized by inflammation-like processes, such as
matrix metalloproteinase expression and cytokine production
[43, 44]. Specifically, members of the innate immune system,
such as the Toll-like receptor, have been identified as
expressed/induced in the granulosa/CC of mouse, bovine
and human ovaries [41]. The activation of these receptors
leads to the activation of many genes, including NFKB and
other transcription factors, cytokines (mainly IL6) and
chemokines, which may improve the COC expansion. Toll-
like receptors may be also involved in fertilization, as it has
been demonstrated that sperm is able to induce the release of
cytokines and chemokines from CC, thereby enhancing the
fertilization process.
Cytokine function in the ovary has also been described as a
process promoting follicular growth, steroidogenesis, recruit-
ment and the activation of leukocytes, all of which are neces-
sary for ovulation and tissue remodelling during ovulation
[45]. Significant changes in the expression levels of key
genes, which are involved in chemokine signaling, were ob-
served and down-regulated in endometriosis CC as compared
with the controls. Sarapik and colleagues have reported that
various cytokines (such as IL8) in the follicular fluid of
infertile women are correlated with a successful pregnancy
following IVF treatments [46]. The IL8 in this study appeared
to be down-regulated in endometriosis CC as compared with
the controls.
CXCL2 is an angiogenic chemokine produced by macro-
phages, endothelial, epithelial and tumor cells, which has
potent chemotactic activity for neutrophils; it thus plays an
important role in cytokine-induced inflammatory and immune
cell-mediated responses [47]. Little data is present in the
literature regarding the role of this chemokine in contributing
to oocyte development. Schindler and colleagues have dem-
onstrated thatCXCL2 is present in ovarian trascriptome during
primordial follicle assembly [48]. CXCL2 appeared to be the
most down-regulated gene in this study of endometriosis
patients, thus indicating a key role for this chemokine in
contributing to tissue remodeling during oocyte maturation.
Several proteins have been identified as being essential for
extracellular matrix formation and the stability of COC. Of
these, the Tumor necrosis factor alpha-induced protein 6
(TNFAIP6), an inflammation-associated protein, has been
widely studied in the formation of the COC extracellular
matrix during ovulation [49, 50]. TNFAIP6 proved to be
significantly down-regulated in this study of endometriosis
CC. Among the other DEGs involved in cell-cell and cell-
ECM adhesion, CD44, which encodes for a cell adhesion
receptor, appeared to be down-regulated in endometriosis
CC. This glycoprotein is present in mature oocytes and pre-
implantation embryos in various species of mammals, such as
humans, but not in immature oocytes [51]. Its expression in
the granulosa cells of endometriosis patients was described as
significantly depressed, thereby suggesting a correlation with
the poor fecundity rate observed in patients with endometri-
osis [52]. Together with TNFAIP6 and CD44, other molecules
involved in cell-cell and cell-ECM interactions (TENASCIN C
and INTEGRIN Β2) have been found to be down-
regula ted in CC from endometr ios is pat ients .
Previously, the presence of TENASCIN C has been
demonstrated in the literature relating to the cumulus
oophorus matrix [53]. Our findings indicate that the
down-regulation of these molecules could affect the
cell-cell interaction in the COC of endometriosis pa-
tients, and this knowledge could be taken into consid-
eration in further studies for an improved understanding
of oocyte impairment in patients with endometriosis.
Concerning the steroidogenic pathway, CYP11A encodes
for the side chain cleavage P450 enzyme, the latter which
converts cholesterol to pregnenolone, thus participating in
estrogen synthesis. This gene has been observed to be down-
regulated in the CC of patients with endometriosis and it could
be another marker of the impaired function of these cells.
RUNX1 encodes for a proangiogenic factor and it has been
found to be significantly up-regulated in the CC of endome-
triosis patients. It has already been described as up-regulated
in rat endometriotic lesions [54]. Whilst belonging to a family
encoding for proteins which are involved in the regulation of
inflammatory processes and cell apoptosis, NLRP2 has been
found to be up-regulated in endometriosis CC and it has been
described in the oocytes and granulosa cells of mice during
folliculogenesis [55].
ARHGAP10 (RHOGTPase activating protein 10) has been
found to be up-regulated in endometriosis CC. However, there
is no experimental evidence of a direct correlation between
this gene and endometriosis. In one study regarding gene
expression in CC as a prognostic factor for embryo viability,
ARHGAP10 was overexpressed in embryos with early cleav-
age, in comparison with embryos which did not cleave early
[14]. The association with other factors involved in angiogen-
esis was claimed by the Authors of this study as the main
reason for this up-regulation.
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We believe the data presented in this Paper to be the first
evidence of the involvement of these up-regulated genes in the
CC of patients with endometriosis but further investigation is
required to improve our understanding of the relationship
between these molecules and the disease. In conclusion, our
data is consistent with the down-regulation in patients with
endometriosis of a large number of genes involved in key
regulatory pathways. We have reported a gene expression
analysis which could offer an improved understanding of the
molecular mechanism responsible for the low fertilization and
implantation rates in patients with endometriosis. Collectively,
these findings appear to be merit further investigation into the
possible markers of fertilization failure in patients with severe
endometriosis.
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